期刊文献+

分化型甲状腺癌术后持续性和(或)复发性颈部淋巴结转移的诊疗

Diagnosis and treatment of postoperative persistent/recurrent cervical lymph nodes metastases in differentiated thyroid cancer
原文传递
导出
摘要 近年来,由于高分辨率超声及细针穿刺抽吸细胞学检查被广泛应用于临床,分化型甲状腺癌(DTC)的检出率显著增加。颈部淋巴结转移(CLNM)是DTC患者术后出现持续性和(或)复发性疾病的最常见类型,其诊疗涉及众多学科。目前诊断CLNM最常用的方法为颈部超声,“金标准”是组织病理学检查,主要的治疗方法仍是手术,131I治疗、超声引导下的消融术治疗及随访观察等代替手术的治疗手段亦逐渐被提出并应用于临床。笔者就DTC术后持续性和(或)复发性CLNM的诊疗作一综述。 In recent years,the detection rate of differentiated thyroid cancer(DTC)has increased significantly due to the wide application of high-resolution ultrasonography and fine needle aspiration biopsy.Cervical lymph nodes metastases(CLNM)is the most common type of postoperative persistent/recurrent disease in DTC patients,and its diagnosis and treatment involve multiple disciplines.At present,the most common diagnostic method and the"gold standard"is cervical ultrasound and histopathological examination respectively.The main treatment is operation.In addition,some alternative treatments such as 131I therapy,ultrasound-guided ablation and follow-up observation have gradually been proposed and applied in clinical practice.The authors review the diagnosis and treatment of postoperative persistent/recurrent CLNM in DTC patients.
作者 张静 陈畅 杨仪 章斌 Zhang Jing;Chen Chang;Yang Yi;Zhang Bin(Department of Nuclear Medicine,the First Affiliated Hospital of Soochow University,Suzhou 215006,China;Department of Nuclear Medicine,Suzhou Science&Technology Town Hospital,Suzhou 215153,China)
出处 《国际放射医学核医学杂志》 2022年第11期692-696,共5页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 分化型甲状腺癌 淋巴结转移 复发 诊断 治疗 持续 Differentiated thyroid cancer Lymph nodes metastases Recurrence Diagnosis Therapy Persistent
  • 相关文献

参考文献9

二级参考文献87

  • 1范建霞,关海霞,吕朝晖,田文,武晓泓,无.妊娠期和产后分化型甲状腺癌促甲状腺激素抑制治疗中国专家共识(2019版)[J].中国实用外科杂志,2020,40(3):255-259. 被引量:12
  • 2黄耿文,杨连粤.甲状腺癌的再次手术治疗[J].中国实用外科杂志,2004,24(10):589-590. 被引量:49
  • 3Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016 [ J ]. CA Cancer J Clin,2016,66( 1 ) :7-30.
  • 4Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[ J]. CA Cancer J Clin,2016,66(2) :115-132.
  • 5Sherman SI. Thyroid carcinoma [ J ]. Lancet, 2003,361 ( 9356 ) : 501-511.
  • 6MazzafexTi EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer[ J l. Am J Med, 1994,97(5 ) :418-428.
  • 7Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999) : tempo- rat trends in initial therapy and long-term outcome in 2444 consecu- tively treated patients[J]. World J Surg,2002,26(8) :879-885.
  • 8Tufano RP, Clayman G, Heller KS, et al. Management of recur- rent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical inter- vention versus active surveillance [ J ]. Thyroid ,2015,25 ( 1 ) : 15-27.
  • 9Haugen BR, Alexander EK, Bible KC, et at. 2015 Americma Thyroid Association Managenlent Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differenti- ated q3tyroid Cancer[J]. Thyroid, 2016,26 ( 1 ) :1-133.
  • 10Machens A, Hinze R, Thomusch O, et al. Pattern of nodal metas- tasis for primary and reoperative thyroid cancer[J]. World J Stag, 2002,26( 1 ) :22-28.

共引文献500

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部